• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

MaxisIT Announces Pioneering SaaS Agreement with Philip Morris International for an Integrated Clinical Data Management Solution

Share:

November 5, 2019

MaxisIT today announced that it has GONE LIVE with MaxisIT’s Integrated Clinical Development Platform together with Tobacco Harm Reduction pioneer, Philip Morris International (PMI). PMI has awarded MaxisIT a multi-year SaaS agreement to use MaxisIT’s Clinical Data Repository, Clinical data management Hub, Statistical computing Environment and Analytics solutions for their global clinical assessment program. This pioneering agreement for MaxisIT’s industry-leading, Integrated Platform, will replace Philip Morris International’s existing solution. With this successful and timely GO LIVE, MaxisIT reinforces its position as an industry innovator in cloud-based clinical data & analytics software solutions for risk-averse and highly regulated industry.

Planning and managing clinical studies have become more complex as the research questions are becoming increasingly more complicated and resource intensive. In order to demonstrate the effectiveness and value of the products being studies, companies must be able to handle the wide variety of data and analyze them timely for faster regulatory review. MaxisIT’s Platform enables “data-driven digital transformation” by delivering complete analytics platform from data ingestion to transformation to analysis and clinical intelligence including data-driven digital applications that truly delivers the value of data, while improving time and reducing costs in clinical development processes by in-time decision-making. This platform’s “Direct-Data-Delivery-Pipe™” intelligently automates the source to insight clinical data value chain for timely review. “At Philip Morris, we are working to develop new products to provide smokers alternative products that are a better option than continuing to smoke cigarettes. Implementing MaxisIT’s solution, will help us stay in the forefront of science, by providing us with a more robust and efficient system for clinical data management and analytics, that will ensure data quality and transparency while ultimately helping us keep pace with the speed of innovation in order to bring scientifically substantiated products to market faster,” said Sharon Carty, Director Clinical Science & Epidemiology Operations, Philip Morris International.

“Increasing variety, volume and complexity of data in clinical trials demands a holistic data strategy for clinical R&D. Data management is struggling to assimilate data across the sources and derive meaningful clinical intelligence for timely decision making,” said Maulik Shah, CEO, MaxisIT. “Industry needs an integrated and intelligent solution that is purpose-built; and supports the entire clinical data value chain in a self-service manner via secured cloud. With over 2000 clinical studies managed in cloud across the customers, MaxisIT’s Platform is delivering value at a faster return on investment,” added by Maulik Shah.

Using MaxisIT’s Integrated Platform, the clinical data management processes can reduce cycle time, achieve greater control over data and respond to quality concerns in time; furthermore, clinical researchers can have faster access to data and self-service insight.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Source: BioSpace

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Sartorius Stedim Biotech to Acquire Novasep’s Chromatography Process Equipment DivisionSartorius Stedim Biotech to Acquire Novasep’s Chromatography Process Equipment Division
  • Digital Diabetes Prevention Program Use Tied to Weight Reduction Among Low-Income Patients with PrediabetesDigital Diabetes Prevention Program Use Tied to Weight Reduction Among Low-Income Patients with Prediabetes
  • Amwell Looks to Third-Party Device Integrations with Launch of ConvergeAmwell Looks to Third-Party Device Integrations with Launch of Converge
  • Abattis Announces Acquisition of European Nutraceutical Company and Provides Corporate UpdatesAbattis Announces Acquisition of European Nutraceutical Company and Provides Corporate Updates
  • Bruker Announces Acquisition of Scientific Software Provider ArxspanBruker Announces Acquisition of Scientific Software Provider Arxspan
  • Option Care and BioScrip Complete Merger to Form Option Care HealthOption Care and BioScrip Complete Merger to Form Option Care Health
  • To Combat COVID-19, Philips Launches Rapid Equipment Deployment KitsTo Combat COVID-19, Philips Launches Rapid Equipment Deployment Kits
  • Pharmacy Inventory Management Software Solutions and Cabinets Market (impact of COVID-19) Growth, Overview with Detailed Analysis 2020-2026Pharmacy Inventory Management Software Solutions and Cabinets Market (impact of COVID-19) Growth, Overview with Detailed Analysis 2020-2026

Trending This Week

  • Pharmaceutical Compliance Software Market 2022 to Showing Impressive Growth By | [no. of Pages: 118] Industry Trends, Share, Size, Top Key Players Analysis and Forecast Research, Shares and Strategies | By Proficient Market Insights
  • Biosimilars Market: Rise in Number of Cancer Patients to Boost Market
  • Biotechnology and Pharmaceutical Services Outsourcing Market Size 2022 Analysis Report By Competitive Vendors in Top Regions and Countries, Production Types, Applications, Growth, Current Trends and Forecast to 2026
  • The Global Wearable Injectors Market Size is Expected to Reach $12.9 Billion By 2028, Rising at a Market Growth of 9.2% CAGR During the Forecast Period
  • Treprostinil Drugs Market – Insights on how Players Have Cemented Their Positions with Disruptive Technologies, Key Players are United Therapeutics, Novartis, and Teva Pharmaceutical Industries Ltd
  • Protect Pharmaceutical Corporation has Acquired Top Notch Software Development Company

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications